Skip to main content

Home/ MaRS/ Group items tagged health care

Rss Feed Group items tagged

Assunta Krehl

Canadian doctor prepares his innovation to fight the next pandemic with the help of a T... - 0 views

  •  
    Sean Fine, Globe and Mail reporter states "Canadian doctor, Kamran Khan, prepares his innovation to fight the next pandemic with the help of Toronto innovation centre, MaRS Discovery District."
Miguel Amante

Toronto's pharmaceutical biotech sector - Next Generation Pharmaceutical - June 2010 - 0 views

  •  
    Toronto is a globally competitive centre for groundbreaking basic and clinical research, with historical and current strengths in areas including new cancer therapeutics, stem cell research and development, genomics, bioinformatics, and the development of new diagnostic and therapeutic tools for every imaginable disease process.
Assunta Krehl

The New Face of Cancer - The Scientist - June 2, 2010 - 0 views

  •  
    The Ontario Institute for Cancer Research (OICR) is applying the newest concepts in life sciences-stem cell therapies, personalized medicine-to one of the oldest diseases.
Assunta Krehl

Ontario Institute for Cancer Research - The Scientist - June 3, 2010 - 0 views

  •  
    The Ontario Institute for Cancer Research (OICR) is a new center of excellence. It is moving Ontario to the forefront of discovery and innovation in cancer research
Miguel Amante

Mining the golden years - Silver Innings - Blog for Senior Citizens - July 16, 2010 - 0 views

  •  
    "Aging is the largest growing business in the world," says Jane Barratt, secretary-general of the Toronto-based International Federation on Ageing. "It's going to happen to all of us."
Cathy Bogaart

OGI Invests in Personalized Medicine for Age-related Macular Degeneration - November 1,... - 0 views

  •  
    The Ontario Genomics Institute has given funding to MaRS life sciences client, ArcticDX. They'll use the money for studies in preparation for a Food and Drug Administration approval for their product. The funding comes through its Pre-Commercialization Business Development Fund (PBDF)
Assunta Krehl

Test-tube industry - Canadian Business - 0 views

  • For Dr. John Evans, growing a strong biotechnology industry is much the same: cities must provide a nurturing environment where science and business can thrive together.
  • That's why Evans, former president of the University of Toronto and current chairman of Torstar Corp., is spearheading the $345-million Medical and Related Science initiative, or MaRS--a petri dish of sorts for commercializing science research. "A lot of intellectual property is being commercialized outside Canada," says Evans. "I think we've been slow in realizing just how important technology developments are to the economic future of the country. MaRS is an attempt to give this a kick into a higher gear." The centrepiece of the MaRS plan, which will officially launch May 12, is a 1.3-million-square-foot, five-building complex in downtown Toronto that will provide office and lab space for small and medium-size companies and incubators, including the not-for-profit Toronto Biotechnology Commercialization Centre. While Evans is reluctant to limit its scope, MaRS will generally focus on health-related technologies, from new drugs and genetic treatments to medical devices and imaging software. Branded a "convergence centre," it will also house a careful mix of support services: intellectual property lawyers, accountants, marketing experts, government funding organizations and venture capital financiers. Plus, start-ups will have access to all the latest equipment on site. For instance, MaRS is in talks with MDS Sciex to supply mass spectrometers, used in proteomics research.
  • But MaRS will be more than just a New Economy real estate development. Evans's intention is to funnel tenants' rent money into services--such as entrepreneurship seminars and angel-matching programs--that MaRS will offer to the broader biotech community. That's why MaRS's location is key: the centre will be built in the heart of what Toronto has dubbed the "Discovery District," a two-square-kilometre chunk of the downtown core, encompassing U of T and four major hospitals. From there, MaRS hopes to act as a network hub across Ontario, with links to research-intensive universities. "None of them," says Evans, "have the critical mass to put it all together on their own."
  • ...3 more annotations...
  • MaRS's primary goal is to get Toronto and the rest of Ontario on the global biotech map. Evans came up with the concept in the late 1990s with Dr. Calvin Stiller, CEO of the labor-sponsored Canadian Medical Discoveries Fund, and Kenneth Knox, a former deputy minister for the Ontario government who's now CEO of MaRS
  • As far as schemes to support fledgling industries go, MaRS is refreshing. To start, it's a nonprofit corporation, not a government program, which will hopefully ensure that it runs more efficiently. The feds and the province of Ontario have each doled out $20 million for MaRS, and Toronto has donated in-kind $4.5 million. More than $12 million has come from a small pool of corporations, including Eli Lilly Canada and MDS, as well as individual donors like Joseph Rotman and Lawrence Bloomberg (who both sit on the MaRS board). U of T pitched in $5 million, and MaRS also did some innovative bond financing to round off the $165 million needed to build Phase I. "It was very important for us to not belong to anybody," says Evans.
  • Now MaRS's challenge is to get the word out. Its posted rate of $26 per square foot is very competitive for prime downtown real estate and is sure to attract attention, especially considering its customized lab space. But MaRS's success won't be measured by a low vacancy rate; getting the right mix of scientists, entrepreneurs and professionals is critical if it plans to commercialize some sustainable businesses. It won't happen overnight--in fact, it may be 10 years before anyone can gauge MaRS's impact. Seems growing a biotech industry isn't quite as easy as growing E. coli in a petri dish.
  •  
    John Evans spearheads the MaRS project which will help to accelerate commercialization for scientific research. The official launch of the MaRS plan will happen on May 12, 2003.
Assunta Krehl

Thoughts and Ideas as Web 2.0 meets Health Care via HealthCamp: Medicine 2.0 lands at M... - 0 views

  • Medicine 2.0 kicks off today (Thursday September 17th, 2009) at the MaRS Centre in Toronto.
  •  
    Mention of the Medicine 2.0 Congress event being held at MaRS Sept 17, 2009.
Sarah Hickman

The Double Helix: A Personal Account of the Discovery of the Structure of DNA: Amazon.c... - 0 views

  •  
    By identifying the structure of DNA, the molecule of life, Francis Crick and James Watson revolutionized biochemistry and won themselves a Nobel Prize. At the time, Watson was only twenty-four, a young scientist hungry to make his mark. His uncompromisingly honest account of the heady days of their thrilling sprint against other world-class researchers to solve one of science's greatest mysteries gives a dazzlingly clear picture of a world of brilliant scientists with great gifts, very human ambitions, and bitter rivalries. With humility unspoiled by false modesty, Watson relates his and Crick's desperate efforts to beat Linus Pauling to the Holy Grail of life sciences, the identification of the basic building block of life. Never has a scientist been so truthful in capturing in words the flavor of his work.
Assunta Krehl

Look who just landed on MaRS - The Globe and Mail - 0 views

  • Look who just landed on MaRS
  • MaRS was known for just that – putting a collective roof over the heads of Canada's out-of-this-universe thinkers. Aside from hosting the unlikely duo of Arnold Schwarzenegger and Dalton McGuinty at a funding announcement two years ago, the centre seems enveloped in galactic silence.
  • corner of College and University
  • ...12 more annotations...
  • the country's most significant collection of scientific and medical researchers.
  • This week, a program called MaRS Innovation announced the appointment of its first full-time president, Raphael (Rafi) Hofstein, a Harvard-trained, Israeli biomedical wizard who wants to bring together companies, scientists and funding under one roof to create a special alchemy of science and shekels.
  • Since its inception, MaRS has focused on turning big ideas into commercial projects. The difference between the two entities is that pretty much anyone with an idea or discovery could come to MaRS for support, regardless of whether they had their “eureka” moment in a state-of-the-art research lab or in their garage. MaRS Innovation, a separate endeavour with its own board of directors, only works with researchers from its 14 partner institutions, which include some of the most prestigious universities and hospitals in Canada. The goal of that project is to do the kind of work those institutions would normally try to do in-house, but on a bigger scale and, the project's backers hope, with better results.
  • MaRS Innovation is very much in its infancy. Officially launched last June, the project is barely a year old, and the board of directors was only announced this February. It has secured about $25-million in funding over five years to be used for commercialization of projects.
  • Dr. Hofstein is giving himself two to three years to roll out a success story – be it the creation of a new small company founded on the back of a researcher's drug discovery and funded by a big pharmaceutical firm, or a new discovery that, packaged properly, attracts serious venture-capital money.
  • The federal government has also taken notice, naming MaRS Innovation as one of 11 new “Centres of Excellence for Commercialization and Research,” a designation that came with almost $15-million in funding.
  • California Governor Arnold Schwarzenegger speaks at MaRs with Premier Dalton McGuinty after a tour of the building in 2007.
  • Indeed, the MaRS Innovation model of pushing for commercial applications of research seems to be directly in line with the philosophy of the Conservative government, which clearly favours practical results when it comes to funding for scientific research.
  • But those tasks involve two separate skill sets, Mr. Tabrizi suggests, and may be much better suited to a place such as MaRS, where academic and industry heavyweights converge.
  • Many of MaRS's biggest partners are in health care, and Dr. Hofstein is jumping in with a list of priorities that includes focusing on stem-cell research and oncology.
  • MaRS itself has always been good at bringing people from various sectors together, but there's no guarantee that Dr. Hofstein's plan will work, especially in the two-to-three-year timeline he mentions when talking about a rollout date for the first MaRS Innovation projects.
  • Indeed, Mr. Tabrizi says some Silicon Valley insiders marvel at what MaRS Innovation is trying to do. “I think there's something innovative there,” he says. “Something different is being done.”
  •  
    MaRS Innovation announced the appointment of its first full-time president, Raphael (Rafi) Hofstein.
Assunta Krehl

7 Opportunities in the Current Recession - Canadian Entrepreneur - 0 views

  • I attended the Wisdom Exchange today at the Mars Discovery District in Toronto, an annual gathering of leading growth firms sponsored by the Ontario government. Ontario’s ministry of small business recognizes that a tiny minority of SMEs, the export-oriented gazelles, account for a disproportionate share of job creation, and it does a great job of encouraging, motivating and supporting the CEOs of such companies through educational opportunities such as the Wisdom Exchange.
  • Jayson Myers, the respected economist who now heads up Canada's largest industry association, Canadian Manufacturers & Exporters.
  • Myers offered a fair bit of bad news to the group – he warned that the recession “will be deeper and last longer than consensus forecasts,” and that total Canadian merchandise exports have actually been falling for six years.
  • ...1 more annotation...
  • But here is the good news. Myers also cited a whole listfull of business opportunities created by the current downturn. Not every company is in a position to seize these opportunities, but those who can should definitely be looking at this list as a recipe for action.Opportunities in the Current Recession:· For companies with cash and investment strength· Replace competitors (who falter or struggle in this economy)· Acquisitions· Respond to new and emerging customer demand· New product and market development· Infrastructure and Innovation (including the smart grid, green energy, health care, logistics and security, and energy – all areas where Canadian companies have some advantages)· Product specialization, services, new processes, new skills
  •  
    Wisdom Exchange Event was held at the MaRS Centre Feb 19, 2009. This event gathers leading growh firms and it is sponsored by the Ontario Government. Jason Myers, head of Canadian Manufacteurers & Exporters mentions the Canadian economy will get worse and last longer but there will be a list of business opportunities.
  •  
    Wisdom Exchange Event was held at the MaRS Centre Feb 19, 2009. This event gathers leading growh firms and it is sponsored by the Ontario Government. Jason Myers, head of Canadian Manufacteurers & Exporters mentions the Canadian economy will get worse and last longer but there will be a list of business opportunities. Feb 19, 2009
Sarah Hickman

Bioentrepreneur - 0 views

  •  
    The site offers tips on how to build a business, access to NPG journals by subject area (biotechnology to development to pharmacology), tool kit downloads, nature news and events, start-up profiles, and a handful of discussion articles on amazing entrepreneurs!
Sarah Hickman

The New Atlantis - A Journal of Technology & Society - 0 views

  •  
    The New Atlantis attempts to clarify the nation's moral and political understanding of all areas of technology-from stem cells to hydrogen cells to weapons of mass destruction. They hope to make sense of the larger questions surrounding technology and human nature, and the practical questions of governing and regulating science. Challenging policymakers who know too little about science, and pushing scientists who often fail to think seriously or deeply about the ethical and social implications of their work.
George Botos

Express Scripts to Test Electronic Pill Container - WSJ.com - 0 views

  •  
    Express Scripts Inc., the big St. Louis pharmacy-benefit manager, is about to test an electronic pill container that issues a series of increasingly insistent reminders, in a national study among patient members. The GlowCap gives electronic reminders and collects data on habits. The container-actually a high-tech top for a standard pill bottle called a "GlowCap"-is equipped with a wireless transmitter that plugs into the wall. When it is time for a dose of medicine, the GlowCap emits a pulsing orange light
Assunta Krehl

The Business of Aging -- Ontario Innovation Summit - Aging In Place Technology Watch - 0 views

  •  
    Laurie Orlov's blog about the Business of Aging Conference that was held at the MaRS Centre on Dec 1 and 2 and sponsored by MaRS and the Ontario Government. The conference was less about business, much more about the social 'phenomenon' of aging and its implications for where and how we live. Dec 6, 2009
Assunta Krehl

Neuroscience and Cognitive Training - Rocketboom - 0 views

  •  
    Rocketboom Tech's Ellie Rountree speaks with Alvaro Fernandez, Founder of SharpBrains, to learn more about the neurology of our brains and cognitive training. Dec 9, 2009
Assunta Krehl

Scotiabank and Baycrest Team Up to bring Hockey Buffs a One-of-a-Kind event... the Scot... - 0 views

  •  
    Scotiabank and Baycrest today officially announced that the Bank will become the title sponsor of the 2010 Scotiabank Pro-Am for Alzheimer's, which expands to two cities this year: Edmonton and Toronto. Earlier this month, Baycrest and Toronto innovation centre MaRS announced the launch of a new company, Cogniciti, that will develop and market brain fitness products aimed at helping adults extend their memory and cognitive abilities longer in the lifespan. Dec 9, 2009
Assunta Krehl

Neuroscience and Cognitive Training - You Tube - 0 views

  •  
    Rocketboom Tech's Ellie Rountree speaks with Alvaro Fernandez, Founder of SharpBrains, to learn more about the neurology of our brains and cognitive training. Dec 9, 2009
Assunta Krehl

Technology To Help Aging Population - Boomer Watch - 0 views

  •  
    Linda Ko blogs about The Business of Aging Summit which was jointly organized by Toronto's innovation incubator, the MaRS Centre, and the Ontario government. This event plans to showcase the work of 14 up-and-coming Ontario companies now developing software, diagnostic tools and other technologies aimed specifically at the aging population. Dec 1, 2009
« First ‹ Previous 41 - 60 of 69 Next ›
Showing 20 items per page